Samsung Gets FDA Nod on New Glass-Free Detector for X-Ray Use
The AccE Glass-Free Detector reportedly combines high-resolution capability with a variety of benefits including improved functionality, enhanced visibility, and a lightweight design.
Emphasizing strong image quality and a portable lightweight design, Samsung has unveiled the new AccE Glass-Free Detector, which recently garnered 510(k) clearance from the Food and Drug Administration (FDA).
Samsung said the 4.5-lb. AccE Glass-Free Detector is 27 percent lighter than conventional X-ray detectors and offers a 76 percent detective quantum efficiency (DQE), according to the company.
The design of the device also reportedly facilitates patient comfort and positioning. Noting compatibility with Samsung’s AccE GM85 mobile digital radiography system, Samsung said the AccE Glass-Free Detector features a side chamfer to assist with lifts, a rear grip for smoother transportation and a flexible panel with center engraving to assist with patient positioning. The device also has a robust load allowance with the capacity to hold up to 881 pounds of surface load and 441 pounds of patient load, according to Samsung.
“We have recognized the need for new solutions that enhance both patient and user comfortability,” noted David Legg, the vice president and head of Boston Imaging, the United States headquarters for Samsung’s digital radiography and ultrasound business. “From the ER to the OR, our glass-free detector exhibits reliability in versatile environments to help get the job done.”
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
